Dr. Christopher Andrews joins M Pharmaceutical board

Christopher Andrews, MD, MSc, FRCPC, a gastroenterologist with the University of Calgary in Canada, has joined the M Pharmaceutical board of directors.

Advertisement

M Pharmaceutical is focused on developing biomedical technologies for obesity and diabetes.

Dr. Andrews focuses on stomach disorders and physiology. He completed advanced training in GI motility and function, as well as a master’s degree in clinical health research, at Mayo Clinic in Rochester, Minn.

More articles on gastroenterology:
Commonwealth Laboratories launches IBS blood test
Global capsule endoscopy market to grow at 11% until 2019: 4 key trends
18k Stretta procedures performed since its introduction

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.